Using circulating tumor DNA (ctDNA) for the early detection of cancer.

The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold new approach for the early detection of cancer. The approach is based on the detection of small amounts of DNA released by small cancers into the blood stream. It is our hope that this approach will allow clinicians to detect small curable cancers. This test is currently under development and is not available clinically at this time.

Видео Using circulating tumor DNA (ctDNA) for the early detection of cancer. канала Johns Hopkins Pathology